How long should we maintain anti-HER2 therapy for...

Future Oncology 2015 / 09

How long should we maintain anti-HER2 therapy for metastatic breast cancer patients with complete remission?

Hacioglu, Bekir, Akin, Serkan, Babacan, Taner, Sever, Ali R, Altundag, Kadri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon.15.165
Date:
September, 2015
File:
PDF, 1.56 MB
english, 2015
Conversion to is in progress
Conversion to is failed